CTOs on the Move

Cardon Outreach

www.cardonoutreach.com

 
Cardon Outreach works tirelessly to reduce the financial burden of medical bills on Americans and on the healthcare providers who serve them. Our work makes a positive difference to thousands of people and hundreds of hospitals and clinics, in communities all over the nation, every day. It is this mission that enables our success at over 800 facilities across 39 states. Over our 20+ years of service we have helped over 24 million individuals, translating into over $100 billion dollars in healthcare spend. Our technology driven, innovative approach to the revenue cycle is prepared to overcome the challenges of the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.cardonoutreach.com
  • 4185 Technology Forest Blvd Suite 200
    The Woodlands, TX USA 77381
  • Phone: 281.296.1771

Executives

Name Title Contact Details

Similar Companies

Saringer Life Science Technologies

Saringer Life Science Technologies Inc. is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VQ OrthoCare

VQ OrthoCare is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

B C Scientific Inc

B C Scientific Inc is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SportsArt

SportsArt is the fitness industry leader in eco-innovation, unique design and green manufacturing excellence; and the only fitness company able to harness human energy and convert it into utility-grade electricity. We`ve built our reputation through rebuilding and sustaining lives in the fitness, medical rehabilitation, performance and wellness markets.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.